Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.4 USD | -2.06% | +1.22% | +2.68% |
30/04 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
26/04 | Wall Street: the worst week of 2024 is followed by the best | CF |
Sales 2024 * | 4.33B 361B | Sales 2025 * | 5.15B 430B | Capitalization | 50.67B 4,229B |
---|---|---|---|---|---|
Net income 2024 * | 715M 59.67B | Net income 2025 * | 897M 74.86B | EV / Sales 2024 * | 12 x |
Net Debt 2024 * | 1.43B 120B | Net Debt 2025 * | 994M 82.98B | EV / Sales 2025 * | 10 x |
P/E ratio 2024 * |
72.6
x | P/E ratio 2025 * |
59
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on DexCom, Inc.
1 day | -2.06% | ||
1 week | +1.22% | ||
Current month | +0.02% | ||
1 month | -8.95% | ||
3 months | +0.29% | ||
6 months | +37.37% | ||
Current year | +2.68% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01/07/01 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01/18/01 |
Chief Tech/Sci/R&D Officer | 47 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20/09/20 |
Mark Foletta
BRD | Director/Board Member | 63 | 19/14/19 |
Eric Topol
BRD | Director/Board Member | 69 | 09/09/09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 0 M€ | +5.54% | - | |
1.04% | 0 M€ | -5.02% |
Date | Price | Change | Volume |
---|---|---|---|
08/24/08 | 127.4 | -2.06% | 1,336,571 |
07/24/07 | 130.1 | +0.35% | 1,425,267 |
06/24/06 | 129.6 | +1.00% | 1,858,416 |
03/24/03 | 128.4 | +1.36% | 1,778,982 |
02/24/02 | 126.6 | +0.61% | 2,311,410 |
Delayed Quote Nasdaq, May 09, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.68% | 50.67B | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+12.66% | 24.62B | |
-0.70% | 24.86B |
- Stock Market
- Equities
- DXCM Stock